Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BMRA stock hub

Biomerica, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BMRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BMRA

In the news

Latest news · BMRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-94.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-69.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BMRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000073290
Company name	Biomerica, Inc.
Country	United States
Country code	US
Cusip	09061H406
Employees	54
Employees Change	-10%
Employees Change Percent	-15.63
Enterprise value	$5.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US09061H4065
Last refreshed	2026-05-10
Market cap	$6.9M
Market cap category	Nano-Cap
Price	$2.22
Price currency	USD
Rev Per Employee	80,129.63x
Sector	Healthcare
Sic	2835
Symbol	BMRA
Website	https://www.biomerica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-60.84%
EV/Sales	1.32x
FCF yield	-46.21%
P/B ratio	2.03x
P/S ratio	1.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-123.67%
EBITDA Margin	-121.75%
Gross margin	4.37%
Gross Profit	$189,000
Gross Profit Growth	-75.2%
Gross Profit Growth3 Y	-43.32%
Gross Profit Growth5 Y	-29.52%
Net Income	$-4.2M
Net Income Growth Years	2%
Pretax Margin	-95.96%
Profit Margin	-96.46%
Profit Per Employee	$-77,296
ROA	-54.58
Roa5y	-33.49
ROCE	-161.3
ROE	-94.32
Roe5y	-68.93
ROIC	-69.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-15.97%
Cagr15y	-3.31%
Cagr1y	-36.11%
Cagr20y	-2.17%
Cagr3y	-42.37%
Cagr5y	-42.47%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	-23.79x
Revenue Growth Q	-11.8x
Revenue Growth Years	0x
Revenue Growth3 Y	-23.15x
Revenue Growth5 Y	-13.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.71
Assets	$4.9M
Cash	$1.3M
Current Assets	$4.1M
Current Liabilities	$1.6M
Debt	$193,000
Debt Equity	$0.06
Equity	$3.3M
Liabilities	$1.6M
Long Term Assets	$755,000
Long Term Liabilities	$0
Net Cash	$1.1M
Net Cash By Market Cap	$16.66
Net Cash Growth	-54.55%
Net Debt Equity	$-0.34
Tangible Book Value	$3.1M
Tangible Book Value Per Share	$1.02
WACC	5.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.64
Inventory Turnover	2.51
Net Working Capital	$1.4M
Quick ratio	1.46
Working Capital	$2.6M
Working Capital Turnover	$1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.46%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-82.44%
1Y total return	-36.09%
200-day SMA	2.57
3Y total return	-80.86%
50-day SMA	2.12
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.69%
All Time High	187.1
All Time High Change	-98.81%
All Time High Date	2020-03-19
All Time Low	1.36
All Time Low Change	63.24%
All Time Low Date	2003-01-06
ATR	0.07
Beta	0.28
Beta1y	1.68
Beta2y	2.1
Ch YTD	-11.9
High	2.22
High52	4.6
High52 Date	2025-08-14
High52ch	-51.74%
Low	2.15
Low52	1.87
Low52 Date	2026-03-06
Low52ch	18.97%
Ma50ch	4.52%
Price vs 200-day SMA	-13.65%
RSI	56.93
RSI Monthly	35.63
RSI Weekly	45.34
Sharpe ratio	-0.54x
Sortino ratio	-0.72
Total Return	-18.46%
Tr YTD	-11.9
Tr15y	-39.67%
Tr1m	2.78%
Tr1w	1.37%
Tr3m	-1.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-5.4M
Operating margin	-123.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,774,024%
Float Percent	89.77%
Shares Insiders	10.23%
Shares Institutions	2.87%
Shares Out	3,090,269
Shares Qo Q	3.51%
Shares Yo Y	18.46%
Short Float	2.2%
Short Ratio	2.86
Short Shares	1.98

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.7M
Average Volume	16,550.75x
Bv Per Share	1.09
Ch10y	-82.44
Ch15y	-39.67
Ch1m	2.78
Ch1w	1.37
Ch1y	-36.1
Ch20y	-35.47
Ch3m	-1.33
Ch3y	-80.86
Ch5y	-93.69
Ch6m	-9.76
Change	1.14%
Change From Open	0
Close	2.2
Days Gap	1.14
Depreciation Amortization	83,000
Dollar Volume	17,233.9
Earnings Date	2026-04-13
Earnings Time	amc
EBIT	$-5.4M
EBITDA	$-5.3M
EPS	$-1.55
F Score	2
FCF	$-3.2M
FCF EV Yield	-55.44x
FCF Per Share	$-1.03
Financing CF	1,458,000
Fiscal Year End	May
Founded	1,971
Income Tax	$22,000
Investing CF	-19,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-13
Last Report Date	2026-02-28
Last Split Date	2025-04-21
Last Split Type	Reverse
Last10k Filing Date	2025-08-29
Ma150	2.39
Ma150ch	-7.23%
Ma20	2.17
Ma20ch	2.45%
Net CF	-1,721,000
Next Earnings Date	2026-08-28
Open	2.22
Optionable	No
Position In Range	100
Post Close	2.22
Postmarket Change Percent	-3.11
Postmarket Price	$2.15
Ppne	270,000
Price Date	2026-05-08
Ptbv Ratio	2.22
Relative Volume	0.47x
Revenue	4,327,000x
SBC By Revenue	11.39x
Share Based Comp	493,000
Tax By Revenue	0.51x
Tr20y	-35.47%
Tr6m	-9.76%
Us State	California
Volume	7,763
Z Score	-14.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BMRA pay a dividend?

Capital-return profile for this ticker.

Performance

BMRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BMRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Float: +89.8% of shares outstanding

Insider ownership

+10.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BMRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.9

Neutral momentum band

Price vs 200-day MA

-13.7%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

-0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BMRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BMRA stock rating?

Biomerica, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BMRA analysis?

The full report lives at /stocks/BMRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BMRA?

The latest report frames BMRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BMRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.